Intravenous fosaprepitant for the prevention of chemotherapy ‐induced vomiting in children: A double‐blind, placebo‐controlled, phase III randomized trial

ConclusionAddition of fosaprepitant to ondansetron and dexamethasone improved chemotherapy ‐induced vomiting control in children treated with moderately or highly emetogenic chemotherapy.

Source: Pediatric Blood and Cancer - November 13, 2018 Category: Cancer & Oncology Authors: Venkatraman Radhakrishnan, Archit Joshi, Jaikumar Ramamoorthy, Swaminathan Rajaraman, Prasanth Ganesan, Trivadi S. Ganesan, Manikandan Dhanushkodi, Tenali G. Sagar Tags: RESEARCH ARTICLE Source Type: research